C

China Resources Pharmaceutical Group Ltd
HKEX:3320

Watchlist Manager
China Resources Pharmaceutical Group Ltd
HKEX:3320
Watchlist
Price: 5.34 HKD -0.56% Market Closed
Market Cap: 33.5B HKD

Wall Street
Price Targets

Price Targets Summary
China Resources Pharmaceutical Group Ltd

Wall Street analysts forecast China Resources Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 7 HKD with a low forecast of 5.96 HKD and a high forecast of 9.03 HKD.

Lowest
Price Target
5.96 HKD
12% Upside
Average
Price Target
7 HKD
31% Upside
Highest
Price Target
9.03 HKD
69% Upside
China Resources Pharmaceutical Group Ltd Competitors:
Price Targets
4502
Takeda Pharmaceutical Co Ltd
17% Upside
NUVB
Nuvation Bio Inc
253% Upside
APLLTD
Alembic Pharmaceuticals Ltd
3% Upside
PAHC
Phibro Animal Health Corp
18% Downside
SUVENPHAR
Suven Pharmaceuticals Ltd
40% Upside
MOC
Molecure SA
210% Upside
AVDL
Avadel Pharmaceuticals PLC
85% Upside

Revenue
Forecast

Revenue Estimate
China Resources Pharmaceutical Group Ltd

For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's revenue is 6%. The projected CAGR for the next 3 years is 8%.

6%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
China Resources Pharmaceutical Group Ltd

For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's operating income is 4%. The projected CAGR for the next 3 years is 11%.

4%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
China Resources Pharmaceutical Group Ltd

For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's net income is 2%. The projected CAGR for the next 3 years is 16%.

2%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is China Resources Pharmaceutical Group Ltd's stock price target?
Price Target
7 HKD

According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 7 HKD with a low forecast of 5.96 HKD and a high forecast of 9.03 HKD.

What is China Resources Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's revenue is 6%. The projected CAGR for the next 3 years is 8%.

What is China Resources Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's operating income is 4%. The projected CAGR for the next 3 years is 11%.

What is China Resources Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's net income is 2%. The projected CAGR for the next 3 years is 16%.

Back to Top